Aurigene partners with Biotech companies in developing cutting-edge, novel ideas from concept to in vivo validation/ lead optimization. The shared-risk/ option deal structures we employ in such collaborations help our partners increase their scientific bandwidth considerably, without a proportionate increase in either monetary or physical resources.

Please email us know more about our partnership models and focus areas.